Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram: A case report

Pharmacopsychiatry

Volumn 39, Issue 5, 2006, Pages 193-194

  Habermeyer, Benedikt ^a   Fuhr, P ^a   Hiss, B ^a   Alber, C ^a   Muller Spahn F ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ACANTHOCYTOSIS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; HOSPITALIZATION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NURSING STAFF; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL;

ADULT; CHOREA; CHOREATIC DISORDERS; CITALOPRAM; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33748574271     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-948329     Document Type: Article

References (14)

1. Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S et al. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 2005; 8: 391-401
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV, 4th ed. Washington, DC: American Psychiatric Association, 1994; 456-463
3. Baxter LR. Basal ganglia systems in ritualistic social displays: reptiles and humans; function and illness. Physiol Behav 2003; 79: 451-460
4. Bruneau MA, Lesperance P, Chouinard S. Schizophrenia-like presentation of neuroacanthocytosis. J Neuropsychiatry Clin Neurosci 2003; 15: 378-380
5. Cummings JL, Cunningham K. Obsessive-compulsive disorder in Huntington's disease. Biol Psychiatry 1992; 31: 263-270
6. De Marchi N, Daniele F, Ragone MA. Fluoxetine in the treatment of Huntington's disease. Psychopharmacology 2001; 153: 264-266
7. Fallon BA, Mathew SJ. Biological therapies for obsessive-compulsive disorder. J Psychiatr Pract 2000; 6: 113-128
8. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psychiatry 1989; 46: 1006-1011
9. Hardie RJ, Pullon HW, Harding AE, Owen JS, Pires M, Daniels GL et al. Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 1991; 114: 13-49
10. Patzold T, Brune M. Obsessive compulsive disorder in Huntington disease: a case of isolated obsessions successfully treated with sertraline. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15: 216-219
11. Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61: 720-730
12. Rossi S, Bartalini S, Ulivelli M, Mantovani A, Di Muro A, Goracci A et al. Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. Biol Psychiatry 2005; 57: 16-20
13. Saiki S, Hirose G, Sakai K, Matsunari I, Higashi K, Saiki M et al. Chorea-acanthocytosis associated with Tourettism. Mov Disord 2004; 19: 833-836
14. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004; 132: 69-79